Neogen Corp (NEOG) stock
NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$10.55−0.30 (-2.76%)
Close on Nov 20, 2026Market cap $2.30BP/E –Yield –
Neogen shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Neogen's shares outstanding was 218M at Aug 31, 2026. For fiscal 2026 it was 218M, up 0.3% from the year before. Over ten years it grew 8.0% a year on average. The highest annual figure on record is 218M in fiscal 2026.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | May 31, 2026 | 218M | +0.3% |
| FY2025 | May 31, 2025 | 217M | +0.2% |
| FY2024 | May 31, 2024 | 217M | +14.6% |
| FY2023 | May 31, 2023 | 189M | +74.9% |
| FY2022 | May 31, 2022 | 108M | +0.8% |
| FY2021 | May 31, 2021 | 107M | +1.3% |
| FY2020 | May 31, 2020 | 106M | +0.8% |
| FY2019 | May 31, 2019 | 105M | +0.5% |
| FY2018 | May 31, 2018 | 104M | +1.9% |
| FY2017 | May 31, 2017 | 102M | +1.3% |
| FY2016 | May 31, 2016 | 101M | +1.2% |
| FY2015 | May 31, 2015 | 100M | +0.5% |
| FY2014 | May 31, 2014 | 99M | +2.1% |
| FY2013 | May 31, 2013 | 97M | +1.3% |
| FY2012 | May 31, 2012 | 96M | +1.0% |
| FY2011 | May 31, 2011 | 95M | +3.0% |
| FY2010 | May 31, 2010 | 92M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | 218M | +0.4% |
| Q4 FY2026CQ2 2026 | May 31, 2026 | 216M | -0.4% |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | 218M | +0.3% |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | 217M | +0.3% |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | 217M | +0.3% |
| Q4 FY2025CQ2 2025 | May 31, 2025 | 217M | +0.2% |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | 217M | +0.2% |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | 217M | +0.2% |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | 217M | -0.1% |
| Q4 FY2024CQ2 2024 | May 31, 2024 | 217M | +0.1% |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | 217M | +0.1% |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | 216M | +0.1% |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | 217M | +101.0% |
| Q4 FY2023CQ2 2023 | May 31, 2023 | 217M | +101.1% |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | 216M | +100.1% |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | 216M | +99.9% |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | 108M | -0.2% |
| Q4 FY2022CQ2 2022 | May 31, 2022 | 108M | -0.4% |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | 108M | +0.7% |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | 108M | +1.2% |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | 108M | +1.4% |
| Q4 FY2021CQ2 2021 | May 31, 2021 | 108M | +1.9% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | 107M | +1.2% |
| Q2 FY2021CQ4 2020 | Nov 30, 2020 | 107M | +1.0% |
| Q1 FY2021CQ3 2020 | Aug 31, 2020 | 107M | +1.1% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | 106M | +1.4% |
| Q3 FY2020CQ1 2020 | Feb 29, 2020 | 106M | +1.1% |
| Q2 FY2020CQ4 2019 | Nov 30, 2019 | 106M | +0.5% |
| Q1 FY2020CQ3 2019 | Aug 31, 2019 | 105M | -0.2% |
| Q4 FY2019CQ2 2019 | May 31, 2019 | 105M | -0.4% |
| Q3 FY2019CQ1 2019 | Feb 28, 2019 | 105M | +0.4% |
| Q2 FY2019CQ4 2018 | Nov 30, 2018 | 105M | +1.2% |
| Q1 FY2019CQ3 2018 | Aug 31, 2018 | 106M | +2.4% |
| Q4 FY2018CQ2 2018 | May 31, 2018 | 105M | +2.7% |
| Q3 FY2018CQ1 2018 | Feb 28, 2018 | 104M | +1.7% |
| Q2 FY2018CQ4 2017 | Nov 30, 2017 | 104M | +1.9% |
| Q1 FY2018CQ3 2017 | Aug 31, 2017 | 103M | – |
| Q4 FY2017CQ2 2017 | May 31, 2017 | 102M | – |
| Q3 FY2017CQ1 2017 | Feb 28, 2017 | 103M | – |
| Q2 FY2017CQ4 2016 | Nov 30, 2016 | 102M | – |
See a number that looks wrong?